Pilot and laboratory level peptide synthesizersDue to differences in equipment positioning (R&D exploration vs. scale transition), application scenarios (small-scale synthesis vs. pilot production), and compliance requirements, there are significant differences in the process validation standards, mainly reflected in validation objectives, core indicators, compliance requirements, sample size, and cycle time

1、 Verify the differences in objectives

The core objective of process validation for laboratory level peptide synthesizers is to confirm the feasibility of the process and explore the boundaries of parameters, providing basic data for subsequent amplification, with a focus on "whether the target peptide can be synthesized" and "the trend of parameter impact on quality";

The process validation of pilot scale equipment aims to confirm the stability and transferability of large-scale production. It is necessary to prove that the process can stably reproduce laboratory level quality levels under pilot scale, while adapting to production level efficiency and compliance requirements. The core is whether it can be produced in batches stably and compliantly.

2、 Differences in core validation indicators

1. Accuracy and uniformity indicators

Laboratory level: focusing on parameter accuracy at low doses, such as:

Reagent delivery accuracy (for μ L dosage, allowable error ± 2%);

Temperature uniformity inside a small volume reaction vessel (± 1 ℃, due to its small volume, temperature is easy to control);

The coupling efficiency of a single reaction (≥ 99% is sufficient, there is no need for strict batch consistency).

Pilot type: Focusing on uniformity and stability after scaling, such as:

High dose reagent delivery accuracy (for mL to L doses, the allowable error should be ≤± 0.5% to avoid cumulative errors affecting the reaction);

Mass transfer efficiency in large volume reaction vessels (resin deposition rate ≤ 5%, ensuring consistent reaction of each part of resin);

The coupling efficiency fluctuates between batches (RSD ≤ 1%, much stricter than the laboratory level ± 2%).

2. Stability and durability indicators

Laboratory level: There is no need to strictly verify the long-term operational stability of the equipment, as the single experiment cycle is short (several hours) and the equipment usage frequency is low (several times a week). The focus of verification is on "parameter stability within a single experiment" (such as temperature fluctuations of ≤± 0.5 ℃ in one synthesis).

Pilot type: The long-term stability of the equipment must be verified, as pilot production often requires continuous operation in multiple batches (1-2 batches per day, lasting for several weeks), with indicators including:

Equipment performance fluctuations during 10 consecutive batches of operation (such as mixing speed deviation of ≤± 5rpm, temperature fluctuations of ≤± 0.5 ℃);

Durability of key components (such as measuring pump seals with a lifespan of ≥ 50 batches to avoid production interruptions caused by frequent maintenance);

Product quality fluctuations between batches (purity RSD ≤ 1.5%, yield RSD ≤ 2%).

3. Relevant indicators for process transfer

Laboratory level: No need to verify the correlation with the "amplification process", only need to confirm the impact of its own process parameters (such as coupling time, reagent ratio) on product quality (such as the trend of purity changes over time), and there is no mandatory requirement to link it to pilot parameters.

Pilot type: It is necessary to verify the consistency with laboratory processes, and the core indicator is the quality deviation between pilot products and laboratory products, such as:

The purity deviation of the main component is ≤ 1% (such as laboratory purity of 95.0%, and pilot scale purity of ≥ 94.0%);

The deviation of key impurities (such as missing peptides and racemates) content is ≤ 0.5%;

Process parameter migration rate (such as coupling time and reagent ratio after pilot optimization, which should be traceable to the amplification logic of laboratory parameters rather than independent new parameters).

3、 Differences in Compliance Requirements

Laboratory level validation focuses more on "scientific rationality" and does not have mandatory compliance requirements; The pilot model needs to be connected to production and must meet GMP related regulations. The validation standards need to incorporate strict compliance elements:

Data integrity: The pilot test certificate must comply with FDA 21 CFR Part 11 and other regulations, requiring all data (parameter settings, sensor records, operation logs) to be traceable and tamper proof, and complete audit trails must be retained (such as who modified the mixing speed and when, and the reason for the modification); At the laboratory level, only critical data needs to be recorded, without strict permission management and log tracing.

Equipment calibration and verification: The verification of pilot equipment must include "equipment lifecycle calibration records", such as calibration certificates for measuring pumps, temperature sensors, and scales (which must be within their validity period), and the calibration interval must meet production level requirements (such as once every 6 months); The calibration cycle of laboratory level equipment can be flexibly set (such as once a year), and can even be temporarily calibrated before the experiment.

Cleaning verification: The pilot model needs to verify the effectiveness of the equipment cleaning program (such as residual solvents ≤ 0.1% to avoid cross contamination between batches), and provide testing data for wiping and rinsing samples; Due to the small number of batches and non medicinal samples, laboratory level cleaning usually only requires simple cleaning and does not require systematic cleaning validation.

4、 The difference between sample size and period

Laboratory level: validation batches are small (usually 3-5 batches), with a short cycle (1-2 weeks), aimed at quickly confirming process trends. For example, to verify the effect of different coupling times on purity, only 3 batches of experiments are needed to obtain trends, without the need for long-term stability data.

Pilot type: Multiple validation batches (at least 10 batches, including continuous production batches), long cycle (1-3 months), and need to cover "long-term operational stability". For example, it is necessary to run 10 batches continuously to verify the purity and yield deviation (RSD ≤ 2%) between the first batch and the tenth batch, while simulating production shutdown, restart, and other scenarios to confirm the process recovery capability.

5、 Differences in risk assessment

The risk assessment of laboratory level validation focuses on the "process failure risk", such as synthesis failure caused by incorrect parameter settings, product purity not meeting standards, etc., and only needs to record the reasons for failure and improvement measures;

The risk assessment of pilot validation should cover the risks of large-scale production, including:

Equipment failure risk (such as the impact of mixing system shutdown on batches);

Cost risk (such as waste caused by excessive reagents, requiring verification of the optimal reagent ratio to control costs);

Compliance risks (such as audit failures caused by incomplete data recording) require the development of risk response plans (such as equipment backup modules and data backup strategies), which should be included in the verification report.

summary

In short, laboratory level validation is "exploratory validation" with flexible standards that focus on feasibility and parameter logic; Pilot verification is a "production oriented compliance verification" with strict standards, focusing on stability, repeatability, and compliance. It is a "qualification certification" from research and development to production. The difference between the two is essentially the manifestation of "R&D thinking" and "production thinking" in the verification standards.